↓ Skip to main content

Postmarketing safety of orphan drugs: a longitudinal analysis of the US Food and Drug Administration database between 1999 and 2018

Overview of attention for article published in Orphanet Journal of Rare Diseases, January 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
16 Mendeley